J&J to buy Momenta in $6.5 bn deal
The acquisition will bolster J&J’s portfolio of drugs for autoimmune diseases
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma deal
Sanofi to acquire Principia Biopharma
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases
SeQuent Scientific to sell stake in Strides Pharma
Arun Kumar’s Family Office, part of the existing promoters of SeQuent Scientific to purchase 3.31 million shares for Rs 1,573…
Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer
The sale is for $425 million upfront plus potential milestone payments of up to $425 million followed by further potential…
Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake
Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada)
The cost of acquisition is about $8.2 million
KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals
KKR will make the investment through its subsidiaries, Tau Investments Holdings, Tau Holdco, and KKR Asia III Fund Investments
The Carlyle Group to acquire majority stake in SeQuent Scientific
The transaction is expected to close in the third quarter of 2020
Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr
The sale is expected to be completed within 10 business days